Our Technology
Our novel SCS delivery technology allows:
Rapid and extensive distribution to the posterior segment and macula
Delivery of high volumes and large particles enabling treatment durability
Ideal for gene and cell therapy, suspensions, and slow-release formulations
How Does It Work?
Proprietary, geometrically-optimized non-sharp tissue separator opens path into SCS, enabling a tangential injection that leads to rapid and extensive distribution.
Press here for full screen
How is our technology different?
Quick and extensive distribution to back of eye and macula
Delivery of large particles and viscous materials
Delivery of large volumes
Low susceptibility to variations in scleral thickness
Limited reflux as a result of tangential entry
Adaptable with standard Luer lock syringes
At least the following patents apply to the Everads Drug Delivery System: US10285852, US11903879, EP3027150, CN105592828, JP6594869, CN112165923, JP7537761
Other patents are pending.